CLINICAL_TRIALS
trial_result
· 2017-08-07
Clinical Trial Update: A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas [Phase 2]
Summary
A Phase II study of everolimus in patients with primary or relapsed chondrosarcoma has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Leon Berard | Conditions: Chondrosarcoma | Phase 2 | Status: SUSPENDED